South Dakota HB 1169: classify medetomidine as a Schedule III controlled substance and establish permissible uses.

Status: Signed by the Governor on 2026-03-09 H.J. 534 (as of 2026-03-09)

State: South Dakota · Session: 2026 · Bill: HB 1169

Subjects: Controlled Substances, Public Health and Safety

Sponsors: Andera, Garcia, Grove, Hunt, Ismay, Jensen (Phil), Jordan, Novstrup, Rice, Schaefbauer

View South Dakota HB 1169 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.